Publications of the SFB 1321

Publications



Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?


Ren, L., Reyes, C. M., Friess, H., and Demir, I. E. (2020). Langenbeck Arch Surg [Epub ahead of print]

In vivo functional screening for systems-level integrative cancer genomics


Weber, J., Braun, C. J., Saur, D., and Rad, R. (2020). Nat Rev Cancer 20, 573-593

Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model


Metzger, P., Kirchleitner, S. V., Boehmer, D. F. R., Horth, C., Eisele, A., Ormanns, S., Gunzer, M., Lech, M., Lauber, K., Endres, S., Duewell, P., Schnurr, M., and Konig, L. M. (2020). Cancer Immunol Immunother 69, 2101-2112

Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19


Koenig, L. M., Boehmer, D. F. R., Metzger, P., Schnurr, M., Endres, S., and Rothenfusser, S. (2020). J Exp Med 217

Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix


Jiang, H., Torphy, R. J., Steiger, K., Hongo, H., Ritchie, A. J., Kriegsmann, M., Horst, D., Umetsu, S. E., Joseph, N. M., McGregor, K., Pishvaian, M. J., Blais, E. M., Lu, B., Li, M., Hollingsworth, M., Stashko, C., Volmar, K., Yeh, J. J., Weaver, V. M., Wang, Z. J., Tempero, M. A., Weichert, W., and Collisson, E. A. (2020). J Clin Invest 130, 4704-4709

Chronic pancreatitis


Beyer, G., Habtezion, A., Werner, J., Lerch, M. M., and Mayerle, J. (2020). Lancet 396, 499-512

Radiosensitization by kinase inhibition revealed by phosphoproteomic analysis of pancreatic cancer cells


Wiechmann, S., Saupp, E., Schilling, D., Heinzlmeir, S., Schneider, G., Schmid, R. M., Combs, S. E., Kuster, B., and Dobiasch, S. (2020). Mol Cell Proteomics [Epub ahead of print]

SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation


Juznic, L., Peuker, K., Strigli, A., Brosch, M., Herrmann, A., Hasler, R., Koch, M., Matthiesen, L., Zeissig, Y., Loscher, B. S., Nuber, A., Schotta, G., Neumeister, V., Chavakis, T., Kurth, T., Lesche, M., Dahl, A., von Massenhausen, A., Linkermann, A., Schreiber, S., Aden, K., Rosenstiel, P. C., Franke, A., Hampe, J., and Zeissig, S. (2020). Gut [Epub ahead of print]

Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology


Dantes, Z., Yen, H. Y., Pfarr, N., Winter, C., Steiger, K., Muckenhuber, A., Hennig, A., Lange, S., Engleitner, T., Ollinger, R., Maresch, R., Orben, F., Heid, I., Kaissis, G. A., Shi, K., Topping, G. J., Stogbauer, F., Wirth, M., Peschke, K., Papargyriou, A., Rezaee-Oghazi, M., Feldmann, K., Schafer, A. P. G., Ranjan, R., Lubeseder-Martellato, C., Stange, D. E., Welsch, T., Martignoni, M. E., Ceyhan, G. O., Friess, H., Herner, A., Liotta, L., Treiber, M., von Figura, G., Abdelhafez, M., Klare, P., Schlag, C., Algul, H., Siveke, J. T., Braren, R. F., Weirich, G., Weichert, W., Saur, D., Rad, R., Schmid, R., Schneider, G., and Reichert, M. (2020). JCI Insight 5

Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma


Li, Q., Maier, S. H., Li, P., Peterhansl, J., Belka, C., Mayerle, J., and Mahajan, U. M. (2020). Radiat Oncol 15, 189